Preferred Name |
dasabuvir |
|
Synonyms |
N-(6-(3-tert-butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl)naphthalen-2-yl)methanesulfonamide |
|
ID |
http://purl.bioontology.org/ontology/MESH/C588260 |
|
altLabel |
N-(6-(3-tert-butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl)naphthalen-2-yl)methanesulfonamide ABT-333 |
|
cui |
C3852512 C3850285 |
|
Has mapping qualifier | ||
HM |
D015081 D014498/Q000031 D013449 |
|
Inverse of RB |
DE54EQW8T1 0 |
|
Mapped to |
http://purl.bioontology.org/ontology/MESH/D014498 |
|
MDA |
20140509 |
|
MeSH Frequency |
227 |
|
MMR |
20210707 |
|
notation |
C588260 |
|
prefLabel |
dasabuvir |
|
SC |
1 |
|
Scope Statement |
an antiviral agent |
|
SRC |
N Engl J Med. 2014 Apr 24;370(17):1594-603. |
|
TERMUI |
T001108605 T859503 T859502 |
|
TH |
FDA SRS (2017) USAN (19XX) INN (19XX) NLM (2014) |
|
tui |
T109 T121 |
Create mapping